Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System

NCT01181479 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1504

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: AG200-15 (cycles 1-13)
DRUG: Lessina crossover to AG200-15

Sponsor

Agile Therapeutics